2 completed, 1 terminated, 1 withdrawn. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Terminated 1, Withdrawn 1 |
Follow LUMIGAN: new trials by email Literature Review of LUMIGAN trials Research Report on LUMIGAN
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension Bimatoprost SR, LUMIGAN - Open-Angle Glaucoma, Ocular Hypertension | Phase 3 | Completed | AbbVie | 37 | 2020-06-11 | 2023-06-08 |
| A Comparative Study of SPARC's SDP-133 Once Daily and Lumigan in Subjects With Open Angle Glaucoma or Ocular Hypertension SDP-133, Lumigan - Open Angle Glaucoma, Ocular Hypertension | Phase 3 | Withdrawn | Sun Pharmaceutical Industries Limited | 2019-06-10 | 2021-11-19 | |
| Stop Retinal Ganglion Cell Dysfunction Study Latanoprost, Bimatoprost, Travoprost - Glaucoma | Phase 3 | Terminated | University of Miami | 28 | 2015-09-01 | 2025-08-26 |
| Study of Bimatoprost Gel on Eyelash Growth Bimatoprost eyelash gel - Madarosis, Hypotrichosis | Phase 3 | Completed | Duke University | 20 | 2007-02-01 | 2014-07-16 |
Ocular Hypertension (3) · Glaucoma, Open-Angle (2) · Glaucoma (1) · Hypotrichosis (1)
AbbVie (1) · Duke University (1) · Sun Pharmaceutical Industries Limited (1) · University of Miami (1)
United States (3)
R01EY014957 (1)